Literature DB >> 104180

Determination of the minimal inhibitory concentration of amphotericin B and miconazole for 21 strains of Aspergillus.

J Martinez, J M Torres, F Arteaga, A Foz-Tena.   

Abstract

The susceptibility of 21 strains of Aspergillus (11 of A. fumigatus, 8 of A, niger, and 2 of A. flavus) isolated from human pathologic specimens to Amphotericin B and Miconazole has been comparatively studied. Determination of the minimal inhibitory concentration of both drugs in a liquid medium showed a noticeably variability for the different strains. The values obtained for Amphotericin B varied between 0.25 microgram/ml (2 strains) and 1.25 microgram/ml (5 strains) after 48 hours, and between 1,25 microgram/ml (1 strain) and 50 microgram/ml (1 strain) after 10 days. For Miconazole the results varied between 0.1 microgram/ml (1 strain) and 25 microgram/ml (1 strain) after 48 hours of incubation, and between 0.5 microgram/ml (5 strains) and greater than 100 microgram/ml after 10 days. The variability of these results indicates the usefulness of carrying our in vitro sensitivity studies whenever it is possible.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 104180     DOI: 10.1007/bf00576365

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  11 in total

1.  Stability of amphotericin B in fungal culture media.

Authors:  S C Cheung; G Medoff; D Schlessinger; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

2.  Miconazole: a review of its antifungal activity and therapeutic efficacy.

Authors:  P R Sawyer; R N Brogden; R M Pinder; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

3.  Miconazole, a broad-spectrum antimycotic agent with antibacterial activity.

Authors:  J M Van Cutsem; D Thienpont
Journal:  Chemotherapy       Date:  1972       Impact factor: 2.544

4.  Susceptibility of Allescheria boydii to amphotericin B.

Authors:  J A Mohr; H G Muchmore
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

5.  Antimicrobial susceptibility testing of six clinical isolates of Aspergillus.

Authors:  M Kitahara; V K Seth; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

6.  Laboratory tests of antifungal drugs.

Authors:  R J Holt
Journal:  J Clin Pathol       Date:  1975-10       Impact factor: 3.411

7.  Sensitivity of Scopulariopsis brevicaulis to some antimicrobial agents.

Authors:  A S Sekhon
Journal:  Mycopathologia       Date:  1975-12-31       Impact factor: 2.574

8.  In vitro susceptibility of isolates of Aspergillus fumigatus and Sporothrix schenckii to amphotericin B.

Authors:  J W Brandsberg; M E French
Journal:  Antimicrob Agents Chemother       Date:  1972-11       Impact factor: 5.191

9.  Antimicrobial activity of econazole and miconazole in vitro and in experimental candidiasis and aspergillosis.

Authors:  G Schär; F H Kayser; M C Dupont
Journal:  Chemotherapy       Date:  1976       Impact factor: 2.544

10.  Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester.

Authors:  P D Hoeprich; A C Huston
Journal:  J Infect Dis       Date:  1976-10       Impact factor: 5.226

View more
  4 in total

1.  Rapid and highly reproducible method for antifungal susceptibility testing of Aspergillus species.

Authors:  H Yamada; S Kohno; S Maesaki; H Koga; M Kaku; K Hara; H Tanaka
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

2.  Susceptibility testing of filamentous fungi to amphotericin B by a rapid radiometric method.

Authors:  W G Merz; D Fay; B Thumar; D Dixon
Journal:  J Clin Microbiol       Date:  1984-01       Impact factor: 5.948

3.  Minimal inhibitory concentrations of lucknomycin, a new polyenic derivative, for Candida and Aspergillus spp.

Authors:  J Martínez-Quesada; J M Torres-Rodriguez; M Rosés-Codinachs; M Amaral-Olivera
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

4.  Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety.

Authors:  Lynn Purkins; Nolan Wood; Katie Greenhalgh; Michael J Allen; Stuart D Oliver
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.